Cerebras vs. SpaceX: Which 2026 IPO Is the Better AI Stock to Own for the Next 5 Years?

Cerebras’ cloud and services revenue surged 287% YoY to $127.7M in Q2, with total non-GAAP revenue up 103.3% to $209.9M, and it raised full-year core revenue guidance to $880M–$890M (from $855M–$865M). The article frames AI inference tailwinds (Gartner: $23.3B inference spend in 2026 vs $19B training) as supportive for Cerebras’ wafer-scale inference hardware, but flags customer concentration (three customers ~76% of Q2 revenue) and slow RPO-to-revenue conversion (only 22% recognized over two years through June 2028). Valuation is compared favorably for Cerebras at ~14.9x 2027 revenue ($2.95B) versus SpaceX at ~17.4x ($105.47B), though SpaceX has a stronger cash-generation base (Connectivity: ~$4.3B revenue and ~$1.7B operating income in Q2) offset by a ~$1.3B AI-segment operating loss and heavy capex ($15.8B).

Analysis

Inference is a utilization game, not a hype-cycle game: the winners will be vendors that can prove durable $/token leadership, power efficiency, and deployment reliability. That favors CBRS only if it can keep utilization high enough to offset concentration risk; otherwise the market will treat this as a narrow customer win rather than a platform inflection, and the multiple should compress quickly when growth inevitably normalizes.

SpaceX’s connectivity cash flow is strategically more valuable than the headline AI segment because it buys time. In practice, that means SPCX has a built-in financing engine for a long-dated AI option, while CBRS is still effectively underwriting growth with a smaller and less diversified customer base. If AI capex remains at current intensity, the market may start to value SPCX’s AI unit on capital efficiency rather than revenue growth alone, which caps near-term upside even if the story stays strong.

The consensus gap is that fast revenue growth is being mistaken for quality of revenue. For CBRS, the key falsifier over the next 1-2 quarters is any slowdown in cloud revenue growth or evidence that bookings are not converting into recognized revenue fast enough to justify the current rerating. For SPCX, the falsifier is a persistent mismatch between AI spend and monetization; if AI capex stays elevated while operating losses widen, the market will likely assign the AI segment a zero or negative value in the next 6-18 months.

Key Decisions for Investors

• CBRS: initiate only a small tactical long on a 10-15% pullback, sized as a 6-12 month satellite position; the thesis is continued inference adoption, but stop if cloud growth decelerates materially for two consecutive quarters.
• SPCX: prefer a modest long as a lower-risk AI option because Connectivity can subsidize the buildout; use it as a quality hedge versus pure-play inference names over a 6-18 month horizon.
• Pair trade: long NVDA / short CBRS for investors who want inference exposure without single-customer concentration risk; this is a 1-3 month relative-value trade if the market starts favoring platform breadth over narrower execution stories.
• Avoid chasing CBRS above current multiple levels until there is evidence that RPO is converting into revenue faster than expected; if conversion stalls, expect rapid multiple compression.
• Set an alert on SPCX AI capex versus connectivity operating income: if AI losses expand faster than the cash engine, fade any rally and look for a re-rating lower over the next 2-4 quarters.